Gene Networks (GNI) is a global pharmaceutical development company that uses novel gene regulatory network based methodologies to efficiently screen, select, validate and exploit new drug targets. We leverage integrated systems biology and gene regulatory network techniques to efficiently create a new class of pharmaceutical agents that are more effective and have fewer side effects than drugs designed with even the most recent genomic methods of discovery.